Skip to main content
. 2018 Feb 26;15(3):350–362. doi: 10.1111/iwj.12872

Figure 6.

Figure 6

(A) Group I: vehicle control (ointment base) (magnified wound contraction view of vehicle control treated diabetic‐induced excision wound model of Wistar albino rats on different days); (B) Group II: standard control (magnified wound contraction view of standard control treated diabetic‐induced excision wound model of Wistar albino rats on different days); (C) Group 3: Cb‐peptide low dose (0.5 mg/mL) (magnified wound contraction view of Cb‐peptide ointment low dose (0.5 mg/mL) treated diabetic‐induced excision wound model of Wistar albino rats on different days); (D) Group IV: Cb‐peptide high dose (1 mg/mL) (magnified wound contraction view of Cb‐peptide ointment high dose (1 mg/mL) treated diabetic‐induced excision wound model of Wistar albino rats on different days)